BBNX
Research Snapshot
Static fundamentals, valuation context, and investor signals for BETA BIONICS, INC. (BBNX).
DCF ready
Valuation
N/A
EV/FCF, N/A FCF yield
Quality
-25.5%
ROIC, -56.1% FCF margin
Growth
N/A
5Y sales (revenue) CAGR
Balance sheet
0.0x
Debt/equity, 8.7x current ratio
Superinvestors
1
Top: First Eagle Investment Management (0.0%)
Strengths to research
- Debt/equity looks manageable at 0.0x.
Watchouts
- Free cash flow margin is negative at -56.1%.
- Valuation multiples are limited or unavailable.
Annual data: 3 periods
Quarterly data: 8 periods
Stock snapshot: May 25, 2026
Static dataset: May 25, 2026
Quality Scorecard
Build-time composite score for BBNX.
Grade F
3
/ 100
Financial Charts
No financial data available for BBNX (annual).
1 superinvestors own BBNX
Current quarter ownership and quarter-over-quarter share changes.
Superinvestor ownership
| Fund | Shares | Value | % Portfolio | QoQ Change |
|---|---|---|---|---|
| First Eagle Investment Management First Eagle Investment Management | 242,000 | $2M | 0.00% | 0.0% |